Trial · NCT03340727
Registered outcomes22
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 22
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Days Between Randomization and Hospital Discharge | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The number of days between randomization and hospital discharge. This outcome is censored at 48 weeks PMA and at time of transfer or death. |
| Primary | Number of Sick Visits Related to Apneic or Apparent Life-threatening Events Within First 4 Weeks Post-discharge | Discharge through 4 weeks post-discharge | Number of sick visits related to apneic or apparent life-threatening events within first 4 weeks post-discharge MEASTYPE=SEC |
| Secondary | The Number of Days to Physiologic Maturity After Randomization | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The number of days to physiologic maturity after randomization. Physiologic maturity is defined: 1. Temperature: out of the incubator for at least 48 hours with normal body temperature; 2. Feeding: oral feeding at a volume of at least 140 ml/kg for 48 hours or growing on less than 140 ml/kg/day for at least 48 hours; 3. Respiratory: apnea-free for at least 5 consecutive days. This outcome is censored at 48 weeks PMA |
| Secondary | The Number of Days to When Out of Incubator for 48 Hours: When Maintained Stable Temp for 48 Hrs | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The number of days to when out of incubator for 48 hours: when maintained stable temp for 48 hrs. This outcome is censored at 48 weeks PMA |
| Secondary | The Number of Days to Apnea/ Bradycardia Free for 5 Consecutive Days | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The number of days to apnea/ bradycardia free for 5 consecutive days. This outcome is censored at 48 weeks PMA |
| Secondary | The Number of Days to Oral Feeds >140 ml/kg/Day or Growing on Less Than 140 ml/kg/Day for at Least 48 Hours | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The number of days oral feeds \>140 ml/kg/day or growing on less than 140 ml/kg/day for at least 48 hours. This outcome is censored at 48 weeks PMA |
| Secondary | Post-menstrual Age at Discharge | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The post-menstrual age of the infant at discharge censored at 48 weeks PMA and at time of transfer or death |
| Secondary | Weight Gain From Randomization Until Status | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | Weight gain from randomization until status %(discharge up to 48 wks PMA, with censoring at time of transfer or death%). |
| Secondary | The Number of Days After Randomization Until Status That Infant Had at Least Two Consecutive Heart Rates >200 Documented at Least 3 Hours Apart | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The number of days after randomization until status that infant had at least two consecutive heart rates \>200 documented at least 3 hours apart |
| Secondary | Treatment for High Blood Pressure | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | Treatment for high blood pressure initiated after randomization until status. |
| Secondary | The Number of Episodes Between Randomization and Status That Infant Was Placed NPO for >= 24 Hours | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The number of episodes between randomization and status that infant was placed NPO for \>= 24 hours |
| Secondary | Use of Anti-reflux Medications | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The use of anti-reflux medications started between randomization and status |
| Secondary | Number of Days That Significant Apnea/Bradycardia | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | The number of days that significant apnea/bradycardia, as defined by documentation of infant receiving any of the following between randomization and status: open label caffeine, other methylxanthines, doxapram, CPAP or ventilatory support for apnea/bradycardia. |
| Secondary | All-cause Mortality | Randomization through hospital discharge, censored at time of transfer, death, or 48 wks PMA | All-cause mortality |
| Secondary | Number of All-cause Readmissions Within First 4 Weeks Post-discharge | Discharge through 4 weeks post-discharge | Number of all-cause readmissions within first 4 weeks post-discharge |
| Secondary | Number of All-cause Readmissions Within Second 4 Weeks Post-discharge | 4 weeks through 8 weeks post-discharge | Number of all-cause readmissions within second 4 weeks post-discharge |
| Secondary | Number of All-cause Readmissions Within First 8 Weeks Post-discharge | Discharge through 8 weeks post-discharge | Number of all-cause readmissions within first 8 weeks post-discharge |
| Secondary | Number of All-cause Sick Visits, Urgent Care, Emergency Rooms, or Health Care Provider%'s Office, Within First 4 Weeks Post-discharge | Discharge through 4 weeks post-discharge | Number of all-cause sick visits, urgent care, emergency rooms, or health care provider%'s office, within first 4 weeks post-discharge |
| Secondary | Number of All-cause Sick Visits, Urgent Care, Emergency Rooms, or Health Care Provider%'s Office, Within Second 4 Weeks Post-discharge | 4 weeks through 8 weeks post-discharge | Number of all-cause sick visits, urgent care, emergency rooms, or health care provider%'s office, within second 4 weeks post-discharge |
| Secondary | Number of All-cause Sick Visits, Urgent Care, Emergency Rooms, or Health Care Provider%'s Office, Within First 8 Weeks Post-discharge | Discharge through 8 weeks post-discharge | Number of all-cause sick visits, urgent care, emergency rooms, or health care provider%'s office, within first 8 weeks post-discharge |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03340727/registered